PCSK9 and metabolic syndrome: In 2019, research showed that patients with stable coronary artery disease low PCSK9 plasma levels were associated with a particular metabolic phenotype (low HDL cholesterol, the metabolic syndrome, obesity, insulin resistance, and diabetes) [32].